Market Overview

Why Ideaya Biosciences Is Trading Higher Today


Ideaya Biosciences (NASDAQ: IDYA) shares are trading higher on Wednesday after Wedbush initiated coverage on the stock with an Outperform rating and announced a price target of $21 per share.

Ideaya Biosciences an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It's engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations.

Ideaya Biosciences shares traded up 7.57% to $14.07 on Wednesday. The stock has a 52-week high of $19.97 and a 52-week low of $2.95.

Latest Ratings for IDYA

Oct 2020WedbushInitiates Coverage OnOutperform
Sep 2020Northland Capital MarketsInitiates Coverage OnOutperform
Jul 2020JP MorganUpgradesNeutralOverweight

View More Analyst Ratings for IDYA
View the Latest Analyst Ratings


Related Articles (IDYA)

View Comments and Join the Discussion!

Posted-In: why it's movingInitiation Analyst Ratings

Latest Ratings

ZSCredit SuisseUpgrades160.0
XONEOppenheimerInitiates Coverage On13.0
ABEOHC Wainwright & Co.Maintains8.0
ONEMorgan StanleyDowngrades
ZSANHC Wainwright & Co.Maintains2.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at